mortality/aging
| N |
• at 7 months, all double mutants are still alive compared to extensive mortality observed in Fas single mutants by this age
|
immune system
|
• number of splenic IgG-secreting cells is dramatically lower than in Fas single mutants
• number of bone marrow IgG-secreting cells is dramatically lower than in Fas single mutants
|
|
• in bone marrow, numbers of CD19+IgM- and CD19+IgD- B cells is increased
|
|
• accumulation of B220+CD3+ cells in spleens and lymph nodes is markedly reduced compared to Fas single mutants
|
|
• serum immunoglobulin levels are significantly reduced compared to Fas single mutants and are similar to Pou2af1-null mice
• serum level of IgA is reduced but not to same extent as IgG
• IgM production is decreased
|
|
• mice do not develop autoantibodies (anti-dsDNA or any IgG antinuclear autoantibodies)
|
hematopoietic system
| N |
• splenic immature and mature B cell numbers are not reduced (a slight increase is observed)
|
|
• number of splenic IgG-secreting cells is dramatically lower than in Fas single mutants
• number of bone marrow IgG-secreting cells is dramatically lower than in Fas single mutants
|
|
• in bone marrow, numbers of CD19+IgM- and CD19+IgD- B cells is increased
|
|
• accumulation of B220+CD3+ cells in spleens and lymph nodes is markedly reduced compared to Fas single mutants
|
|
• serum immunoglobulin levels are significantly reduced compared to Fas single mutants and are similar to Pou2af1-null mice
• serum level of IgA is reduced but not to same extent as IgG
• IgM production is decreased
|
renal/urinary system
|
• no IgG or C3 deposition is observed, but crescent formation and enlargement of glomeruli is observed
• no inflammation is observed
|
|
• crescent formation is observed
|
|
• enlargement of glomeruli is observed
|


Analysis Tools